Literature DB >> 15161866

Progressive cone dystrophy associated with mutation in CNGB3.

Michel Michaelides1, Irene A Aligianis, John R Ainsworth, Peter Good, John D Mollon, Eamonn R Maher, Anthony T Moore, David M Hunt.   

Abstract

PURPOSE: To determine the molecular basis for phenotypic variability in a three-generation consanguineous family containing a single individual with complete achromatopsia and three individuals with progressive cone dystrophy.
METHODS: Four affected individuals underwent ophthalmic examination, electrophysiological assessment, color fundus photography, and psychophysical testing. Blood samples were obtained for DNA extraction and mutation screening of the cone-specific cGMP-gated (CNG) channel protein gene CNGB3 was undertaken.
RESULTS: The clinical findings in one family member were consistent with a diagnosis of complete achromatopsia, with nystagmus, photophobia, and poor visual acuity from early infancy and complete color-blindness, normal fundi, and absent cone responses with normal rod responses on electroretinography (ERG). Mutation analysis revealed her to be homozygous for the common CNGB3 achromatopsia mutation, 1148delC (Thr383fs). In contrast, the three other symptomatic individuals in the family had findings consistent with progressive cone dystrophy. Their visual problems began later in childhood (ranging from 3 to 14 years of age) and there was evidence of progressive deterioration in cone function. All three had a marked tritanopic color vision defect and fundoscopy revealed bilateral macular atrophy. Electrophysiological testing of these three subjects demonstrated clear evidence of progressive deterioration of cone responses over time; rod responses were normal. All three individuals with this progressive phenotype were found to be compound heterozygotes for the 1148delC (Thr383fs) frameshift mutation and a novel Arg403Gln missense mutation in CNGB3.
CONCLUSIONS: Mutations in CNGB3, which have been shown to cause achromatopsia, are now shown to be associated with autosomal recessive progressive cone dystrophy. In this study, a novel Arg403Gln mutation was identified, located in the middle of the pore domain of the cone CNG cation channel beta-subunit, which when associated with the nonsense mutation Thr383fs, resulted in progressive cone dystrophy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161866     DOI: 10.1167/iovs.03-0898

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  27 in total

1.  Analysis of the ABCA4 gene by next-generation sequencing.

Authors:  Jana Zernant; Carl Schubert; Kate M Im; Tomas Burke; Carolyn M Brown; Gerald A Fishman; Stephen H Tsang; Peter Gouras; Michael Dean; Rando Allikmets
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

2.  A homologous genetic basis of the murine cpfl1 mutant and human achromatopsia linked to mutations in the PDE6C gene.

Authors:  Bo Chang; Tanja Grau; Susann Dangel; Ron Hurd; Bernhard Jurklies; E Cumhur Sener; Sten Andreasson; Helene Dollfus; Britta Baumann; Sylvia Bolz; Nikolai Artemyev; Susanne Kohl; John Heckenlively; Bernd Wissinger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-03       Impact factor: 11.205

3.  Genotype-dependent variability in residual cone structure in achromatopsia: toward developing metrics for assessing cone health.

Authors:  Adam M Dubis; Robert F Cooper; Jonathan Aboshiha; Christopher S Langlo; Venki Sundaram; Benjamin Liu; Frederick Collison; Gerald A Fishman; Anthony T Moore; Andrew R Webster; Alfredo Dubra; Joseph Carroll; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-02       Impact factor: 4.799

4.  X-linked cone dystrophy caused by mutation of the red and green cone opsins.

Authors:  Jessica C Gardner; Tom R Webb; Naheed Kanuga; Anthony G Robson; Graham E Holder; Andrew Stockman; Caterina Ripamonti; Neil D Ebenezer; Olufunmilola Ogun; Sophie Devery; Genevieve A Wright; Eamonn R Maher; Michael E Cheetham; Anthony T Moore; Michel Michaelides; Alison J Hardcastle
Journal:  Am J Hum Genet       Date:  2010-06-24       Impact factor: 11.025

5.  Retinal morphology of patients with achromatopsia during early childhood: implications for gene therapy.

Authors:  Paul Yang; Keith V Michaels; Robert J Courtney; Yuquan Wen; Daniel A Greninger; Leah Reznick; Daniel J Karr; Lorri B Wilson; Richard G Weleber; Mark E Pennesi
Journal:  JAMA Ophthalmol       Date:  2014-07       Impact factor: 7.389

Review 6.  The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness.

Authors:  R Lane Brown; Timothy Strassmaier; James D Brady; Jeffrey W Karpen
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 7.  [Genetic causes of hereditary cone and cone-rod dystrophies].

Authors:  S Kohl
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

8.  Rod and rod-driven function in achromatopsia and blue cone monochromatism.

Authors:  Anne Moskowitz; Ronald M Hansen; James D Akula; Susan E Eklund; Anne B Fulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-29       Impact factor: 4.799

9.  Homozygosity mapping reveals PDE6C mutations in patients with early-onset cone photoreceptor disorders.

Authors:  Alberta A H J Thiadens; Anneke I den Hollander; Susanne Roosing; Sander B Nabuurs; Renate C Zekveld-Vroon; Rob W J Collin; Elfride De Baere; Robert K Koenekoop; Mary J van Schooneveld; Tim M Strom; Janneke J C van Lith-Verhoeven; Andrew J Lotery; Norka van Moll-Ramirez; Bart P Leroy; L Ingeborgh van den Born; Carel B Hoyng; Frans P M Cremers; Caroline C W Klaver
Journal:  Am J Hum Genet       Date:  2009-07-16       Impact factor: 11.025

Review 10.  Function and dysfunction of CNG channels: insights from channelopathies and mouse models.

Authors:  Martin Biel; Stylianos Michalakis
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.